NAT detected 42 blood donor sera as

NAT detected 42 blood donor sera as ZIKV RNA reactive of 1505 tested (2.8%). Thirty ZIKV RNA-reactive blood products collected before the implementation of NAT were transfused to 26 recipients. Posttransfusion investigations were conducted by the hemovigilance unit and data were available for 12 recipients. Symptomatic ZIKV-TT infections were not reported.

結果 (繁體中文) 1:

NAT檢測42的血液供體血清作為ZIKV RNA反應性的測試1505（2.8％）。三十NAT實施之前收集ZIKV RNA反應的血液製品輸血了26收件人。輸血後調查是由hemovigilance單位進行的，數據是可用的12個接收者。未報告有症狀的ZIKV-TT感染。

結果 (繁體中文) 2:

NAT檢測出42個獻血者血清為ZIKVRNA反應反應1505測試（2.8%）。在NAT實施之前收集的30個ZIKVRNA反應血製品被轉給26個接受者。輸血後調查由血液警戒股進行，12名接受者有資料。沒有報告有症狀的ZIKV-TT感染。

結果 (繁體中文) 3:

nat檢測出42份獻血者血清為zikv rna反應性或1505份（2.8%）。在實施NAT前採集的30種ZikV RNA反應性血製品輸注給26名受者。輸血後的調查由血液警戒部門進行，數據可供12名接受者使用。未報告症狀性Zikv-TT感染。